Suzuki, Shiori http://orcid.org/0000-0001-5762-850X
Katagiri, Ryoko http://orcid.org/0000-0002-4867-2450
Yamaji, Taiki
Sawada, Norie
Imatoh, Takuya
Ihira, Hikaru
Inoue, Manami http://orcid.org/0000-0003-1276-2398
Tsugane, Shoichiro http://orcid.org/0000-0003-4105-2774
Iwasaki, Motoki
Sawada, N.
Tsugane, S.
Iwasaki, M.
Inoue, M.
Yamaji, T.
Katagiri, R.
Miyamoto, Y.
Ihira, H.
Abe, S. K.
Tanaka, S.
Moriya, T.
Minamizono, T.
Shirai, Y.
Kuniyoshi, H.
Yoshimi, T.
Sonoda, H.
Tagami, T.
Ando, T.
Kimura, T.
Kokubo, Y.
Yamagishi, K.
Mizoue, T.
Nakamura, K.
Takachi, R.
Ishihara, J.
Iso, H.
Kitamura, T.
Saito, I.
Yasuda, N.
Mimura, M.
Sakata, K.
Noda, M.
Goto, A.
Yatsuya, H.
,
Funding for this research was provided by:
National Cancer Center Research and Development Fund
Japan Agency for Medical Research and Development (JP16ck0106095, JP19ck0106266)
Article History
Received: 20 August 2021
Revised: 10 January 2022
Accepted: 21 January 2022
First Online: 10 February 2022
Ethics approval and consent to participate
: All precedures complied with the Helsinki Declaration. The comprehensive study protocol, including this study, was approved by the Institutional Review Board of the National Cancer Center, Tokyo, Japan (Approval No.2011-044). Before initiating this study, all living participants who had provided blood were contacted by mail and given the opportunity to opt-out of participation. Additionally, information on the study was posted on the website of our center to provide participants with the opportunity to opt-out at any time. Respondents who refused to participate were excluded from this study and their withdrawal of consent was documented.
: This manuscript does not contain any individual person’s data in any form, thus, consent for publication was not required.
: The authors declare no competing interests.